ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,336 | -27.4% | 51,697 | -8.8% | 0.00% | 0.0% |
| Q2 2023 | $475,814 | +411.6% | 56,712 | +170.6% | 0.00% | – |
| Q1 2022 | $93,000 | -11.4% | 20,956 | -20.0% | 0.00% | – |
| Q4 2021 | $105,000 | -54.3% | 26,203 | 0.0% | 0.00% | – |
| Q3 2021 | $230,000 | -69.7% | 26,203 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $759,000 | +772.4% | 66,960 | +90.6% | 0.00% | – |
| Q1 2020 | $87,000 | -56.9% | 35,132 | +1.2% | 0.00% | – |
| Q4 2019 | $202,000 | +10.4% | 34,724 | 0.0% | 0.00% | – |
| Q3 2019 | $183,000 | -12.0% | 34,724 | 0.0% | 0.00% | – |
| Q2 2019 | $208,000 | -30.4% | 34,724 | +5.0% | 0.00% | -100.0% |
| Q1 2019 | $299,000 | +9.1% | 33,068 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $274,000 | -18.5% | 33,068 | +35.7% | 0.00% | 0.0% |
| Q3 2018 | $336,000 | +73.2% | 24,369 | 0.0% | 0.00% | – |
| Q2 2018 | $194,000 | – | 24,369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 473,446 | $5,625,000 | 4.61% |
| Knoll Capital Management, LLC | 569,405 | $6,765,000 | 4.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 321,879 | $3,824,000 | 2.09% |
| First Light Asset Management, LLC | 2,624,001 | $31,173,000 | 2.07% |
| Mesirow Financial Investment Management, Inc. | 63,634 | $756,000 | 2.06% |
| Ghost Tree Capital, LLC | 650,000 | $7,722,000 | 1.82% |
| Altium Capital Management LP | 548,225 | $6,513,000 | 1.81% |
| Perceptive Advisors | 8,703,879 | $103,402,000 | 1.31% |
| Affinity Asset Advisors, LLC | 300,000 | $3,564,000 | 1.21% |
| Avidity Partners Management LP | 2,552,000 | $30,318,000 | 0.84% |